GT Biopharma (GTBP) vs Phio Pharmaceuticals (PHIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GT Biopharma (GTBP) has outperformed Phio Pharmaceuticals (PHIO) over the past year, gaining 724.5% versus a loss of 57.5%. Over five years, GTBP leads with a -96.6% price change compared with -99.4% for PHIO. Phio Pharmaceuticals is the larger company by market cap ($11.5 million vs $10.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GTBP | PHIO |
|---|---|---|
| Share price | $6.06 | $0.9898 |
| Market cap | $10.93M | $11.50M |
| 1-day change | -2.29% | -1.02% |
| YTD return | +689.81% | -4.81% |
| 1-year return | +724.47% | -57.47% |
| 5-year return | -96.58% | -99.45% |
| EPS (TTM) | $-147.50 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.75 | $4.19 |
| 52-week low | $4.91 | $0.813 |
| Distance from 52-week high | -78.92% | -76.38% |
| Average volume | 55.55K | 584.05K |
| Shares outstanding | 1.80M | 11.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GTBP has outperformed PHIO by 781.9 percentage points over the past year.
GTBP vs PHIO FAQ
Which is bigger, GT Biopharma or Phio Pharmaceuticals?
Phio Pharmaceuticals (PHIO) is larger, with a market capitalization of $11.50M compared with $10.93M for GT Biopharma (GTBP).
Which stock has performed better over the past year, GTBP or PHIO?
GTBP returned +724.47% over the past 12 months, compared with -57.47% for PHIO (price return, excluding dividends). Past performance does not predict future results.
Are GT Biopharma and Phio Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.